{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:52:18Z","timestamp":1767135138078,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012979.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000}}],"reference-count":82,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012979.pub3","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T12:49:05Z","timestamp":1649335745000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Medical interventions for chronic rhinosinusitis in cystic fibrosis"],"prefix":"10.1002","volume":"2022","author":[{"given":"Tulasi Kota","family":"Karanth","sequence":"additional","affiliation":[{"name":"Kasturba Medical College; Manipal University; Karnataka India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena Kota Laxminarayan KL","family":"Karanth","sequence":"additional","affiliation":[{"name":"Department of Surgery; Kasturba Medical College and Hospital; Manipal India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan K","family":"Ward","sequence":"additional","affiliation":[{"name":"Division of Otology, Neurotology and Skull Base Surgery; Johns Hopkins Hospital; Baltimore Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford A","family":"Woodworth","sequence":"additional","affiliation":[{"name":"University of Alabama; Birmingham USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laxminarayan","family":"Karanth","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Melaka-Manipal Medical College, Manipal Academy of Higher Education (MAHE); Melaka Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"10.1002\/14651858.CD012979.pub3-BIB0001|cit1","unstructured":"A randomised trial of therapeutic ultrasound for chronic rhinosinusitis in adults with cystic fibrosis www.anzctr.org.au"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0002|cit2","first-page":"322","article-title":"Tobramycin and hyaluronic acid nasal solution: beyond antimicrobial effect","volume":"46 Suppl 34","author":"Claut","year":"2011","journal-title":"Pediatric Pulmonology"},{"issue":"4","key":"10.1002\/14651858.CD012979.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jcf.2014.02.006","article-title":"Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis","volume":"13","author":"Di Cicco","year":"2014","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0004|cit4","unstructured":"Pilot study to evaluate the local tolerability and efficacy of a new tobramycin 3% nasal spray formulation to reduce the bacterial density of Pseudomonas aeruginosa and\/or Staphylococcus aureus, in patients affected by cystic fibrosis with rhinosinusal infection - ND www.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2007-003628-39-IT"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0005|cit5","unstructured":"The effect of compound honey syrup on chronic sinusitis in cystic fibrosis patients www.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20201009048976N1"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/coa.13637","article-title":"Manuka honey versus saline sinus irrigation in the treatment of cystic fibrosis-associated chronic rhinosinusitis: a randomised pilot trial","volume":"46","author":"Lee","year":"2021","journal-title":"Clinical Otolaryngology"},{"issue":"2","key":"10.1002\/14651858.CD012979.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.anl.2010.09.001","article-title":"Sinonasal inhalation of dornase alfa in CF: A double-blind placebo-controlled cross-over pilot trial","volume":"38","author":"Mainz","year":"2011","journal-title":"Auris Nasus Larynx"},{"issue":"5","key":"10.1002\/14651858.CD012979.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jcf.2014.07.003","article-title":"Nasal saline as a placebo in chronic rhinosinusitis","volume":"13","author":"Karadag","year":"2014","journal-title":"Journal of Cystic Fibrosis"},{"issue":"4","key":"10.1002\/14651858.CD012979.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2014.02.005","article-title":"Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: a double-blind placebo-controlled cross-over trial","volume":"13","author":"Mainz","year":"2014","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1569-1993(10)60089-6","article-title":"Sinonasal inhalation of dornase alfa reduces rhinosinusitis symptoms in CF. Results of a DBPC-cross-over-study","volume":"9 Suppl 1","author":"Mainz","year":"2010","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S1569-1993(15)30323-4","article-title":"Sinonasal inhalation of isotonic vs. hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - results of a multicentre, double-blind, controlled prospective trial","volume":"14 Suppl 1","author":"Mainz","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1002\/14651858.CD012979.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jcf.2016.05.003","article-title":"Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - Results of a multicenter, prospective, randomized, double-blind, controlled trial","volume":"15","author":"Mainz","year":"2016","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0013|cit13","unstructured":"Nasally delivered pulmozyme for sinusitis in cystic fibrosis www.clinicaltrials.gov\/show\/nct00416182"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0014|cit14","unstructured":"Efficacy of nasal irrigation with Respimer\u00ae Netiflow\u00ae vs saline among patients with cystic fibrosis and chronic rhinosinusitis www.clinicaltrials.gov\/show\/NCT03145051"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0015|cit15","unstructured":"Ivacaftor for acquired CFTR dysfunction in chronic rhinosinusitis www.clinicaltrials.gov\/ct2\/show\/NCT03439865"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD012979.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00005537-199902000-00017","article-title":"Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus","volume":"109","author":"Wagner","year":"1999","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1521-2254(199901\/02)1:1<13::AID-JGM6>3.0.CO;2-G","article-title":"Maxillary sinusitis as a surrogate model for CF gene therapy clinical trials in patients with antrostomies","volume":"1","author":"Wagner","year":"1999","journal-title":"Journal of Gene Medicine"},{"issue":"9117","key":"10.1002\/14651858.CD012979.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/S0140-6736(05)77740-0","article-title":"Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus [letter]","volume":"351","author":"Wagner","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0019|cit19","first-page":"260","article-title":"A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF in the maxillary sinus of CF patients","volume":"Suppl 17","author":"Wagner","year":"1998","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0020|cit20","first-page":"223","article-title":"A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in CF patients with antrostomies","volume":"Suppl 19","author":"Wagner","year":"1999","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD012979.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/hum.1998.9.6-889","article-title":"A phase I\/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis","volume":"9","author":"Wagner","year":"1998","journal-title":"Human Gene Therapy"},{"issue":"11","key":"10.1002\/14651858.CD012979.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/104303402760128577","article-title":"A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies","volume":"13","author":"Wagner","year":"2002","journal-title":"Human Gene Therapy"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0023|cit23","unstructured":"Tobramycin delivered by nebulized sonic aerosol for chronic rhinosinusitis treatment of cystic fibrosis patients (AVASMUC) www.clinicaltrials.gov\/ct2\/show\/NCT02888730"},{"issue":"21","key":"10.1002\/14651858.CD012979.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012979.pub3-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008253.pub4","article-title":"Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis","author":"Beer","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012979.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/lary.21921","article-title":"Transepithelial ion transport is suppressed in hypoxic sinonasal epithelium","volume":"121","author":"Blount","year":"2011","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1002\/14651858.CD012979.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00005537-199903000-00010","article-title":"Physiologic and hypertonic saline solutions impair ciliary activity in vitro","volume":"109","author":"Boek","year":"1999","journal-title":"Laryngoscope"},{"issue":"7","key":"10.1002\/14651858.CD012979.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10096-016-2640-x","article-title":"Microbiology of chronic rhinosinusitis","volume":"35","author":"Brook","year":"2016","journal-title":"European Journal of Clinical Microbiology and Infectious Disease"},{"issue":"3","key":"10.1002\/14651858.CD012979.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcf.2008.03.009","article-title":"Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice","volume":"7","author":"Castellani","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD012979.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/alr.21252","article-title":"New insights into the pathogenesis of cystic fibrosis sinusitis","volume":"4","author":"Chang","year":"2014","journal-title":"International Forum of Allergy & Rhinology"},{"issue":"12","key":"10.1002\/14651858.CD012979.pub3-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000407.pub4","article-title":"Oral steroids for long-term use in cystic fibrosis","author":"Cheng","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5058","key":"10.1002\/14651858.CD012979.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.256.5058.774","article-title":"Cystic fibrosis: molecular biology and therapeutic implications","volume":"256","author":"Collins","year":"1992","journal-title":"Science"},{"issue":"1-4","key":"10.1002\/14651858.CD012979.pub3-BIB0033|cit33","first-page":"220","article-title":"Nasal polyposis in cystic fibrosis treated by beclomethasone dipropionate","volume":"36","author":"Costantini","year":"1990","journal-title":"Acta Universitatis Carolinae. Medica"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0034|cit34","unstructured":"Cystic Fibrosis Mutation Database www.genet.sickkids.on.ca\/StatisticsPage.html"},{"issue":"6","key":"10.1002\/14651858.CD012979.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jcf.2014.09.005","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation","volume":"13","author":"De Boeck","year":"2014","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0036|cit36","unstructured":"Deeks JJ Higgins JP Altman DG on behalf of theCSMG Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD012979.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"749\u201367","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"Doring","year":"2000","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-462003-2.50006-7","article-title":"Molecular biology of cystic fibrosis","volume":"3","author":"Drumm","year":"1993","journal-title":"Molecular Genetic Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0040|cit40","first-page":"185","article-title":"Inhaled aztreonam therapy in patients with cystic fibrosis colonized with Pseudomonas aeruginosa","volume":"40","author":"Fernandez","year":"1994","journal-title":"Anales Espanoles De Pediatria"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"issue":"8","key":"10.1002\/14651858.CD012979.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012979.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1164\/rccm.200403-381WS","article-title":"Macromolecular interactions and ion transport in cystic fibrosis","volume":"170","author":"Guggino","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.rmcr.2016.10.012","article-title":"The use of ivacaftor in CFTR mutations resulting in residual functioning protein","volume":"19","author":"Guigui","year":"2016","journal-title":"Respiratory Medicine Case Reports"},{"issue":"2","key":"10.1002\/14651858.CD012979.pub3-BIB0045|cit45","first-page":"63","article-title":"A prospective treatment trial of nasal polyps in adults with cystic fibrosis","volume":"38","author":"Hadfield","year":"2000","journal-title":"Rhinology"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0046|cit46","unstructured":"Higgins JP Deeks JJ Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0047|cit47","unstructured":"Higgins JP Altman DG Sterne JA editor(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0048|cit48","unstructured":"Higgins JP Deeks JJ Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD012979.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1183\/09031936.02.00248102","article-title":"A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis","volume":"20","author":"Hodson","year":"2002","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.TP.0000100467.74330.49","article-title":"Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience","volume":"77","author":"Holzmann","year":"2004","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD012979.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MCP.0000000000000107","article-title":"Management of the upper airway in cystic fibrosis","volume":"20","author":"Illing","year":"2014","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012979.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI117789","article-title":"Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells","volume":"95","author":"Johnson","year":"1995","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-5876(93)90143-Q","article-title":"The results of functional endoscopic sinus (FES) surgery on the symptoms of patients with cystic fibrosis","volume":"28","author":"Jones","year":"1993","journal-title":"International Journal of Pediatric Otorhinolaryngology"},{"issue":"6069","key":"10.1002\/14651858.CD012979.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.335.6069.645","article-title":"Personalized medicine. New cystic fibrosis drug offers hope, at a price","volume":"335","author":"Kaiser","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1590\/S1806-37132015000100009","article-title":"Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment","volume":"41","author":"Kang","year":"2015","journal-title":"Jornal Brasileiro de Pneumologia"},{"issue":"10","key":"10.1002\/14651858.CD012979.pub3-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012979.pub2","article-title":"Medical interventions for chronic rhinosinusitis in cystic fibrosis","author":"Karanth","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012979.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/alr.21431","article-title":"Chronic rhinosinusitis and cystic fibrosis: the interaction between sinus bacteria and mucosal immunity","volume":"5","author":"Kim","year":"2015","journal-title":"International Forum of Allergy & Rhinology"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD012979.pub3-BIB0058|cit58","first-page":"S75","article-title":"Asthma and the unified airway","volume":"136","author":"Krouse","journal-title":"Otolaryngology and Head and Neck Surgery"},{"issue":"4","key":"10.1002\/14651858.CD012979.pub3-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004197.pub5","article-title":"Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis","author":"Langton Hewer","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012979.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/lary.24503","article-title":"Medical management of chronic rhinosinusitis in cystic fibrosis: a systematic review","volume":"124","author":"Liang","year":"2014","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1002\/14651858.CD012979.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00405-012-2124-2","article-title":"Smell in cystic fibrosis","volume":"270","author":"Lindig","year":"2013","journal-title":"European Archives of Oto-rhino-laryngology"},{"issue":"4","key":"10.1002\/14651858.CD012979.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/153.4.345","article-title":"Predictive 5-year survivorship model of cystic fibrosis","volume":"153","author":"Liou","year":"2001","journal-title":"American Journal of Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012979.pub3-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11882-012-0250-y","article-title":"Pathogenesis and management of nasal polyposis in cystic fibrosis","volume":"12","author":"Mainz","journal-title":"Current Allergy and Asthma Reports"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0064|cit64","first-page":"S3","article-title":"International Consensus Statement on Allergy and Rhinology: Rhinosinusitis Executive Summary","volume":"6 Suppl 1","author":"Orlandi","year":"2016","journal-title":"International Forum of Allergy & Rhinology"},{"issue":"3 pt 2","key":"10.1002\/14651858.CD012979.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0091-6749(92)90183-3","article-title":"Impact of sinusitis in cystic fibrosis","volume":"90","author":"Ramsey","year":"1992","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group","volume":"340","author":"Ramsey","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/1099-0496(200101)31:1<13::AID-PPUL1001>3.0.CO;2-N","article-title":"Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis","volume":"31","author":"Ratjen","year":"2001","journal-title":"Pediatric Pulmonology"},{"issue":"7","key":"10.1002\/14651858.CD012979.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(17)30215-1","article-title":"Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial","volume":"5","author":"Ratjen","year":"2017","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0069|cit69","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"2","key":"10.1002\/14651858.CD012979.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-5876(01)00556-0","article-title":"Endoscopic sinus surgery in cystic fibrosis: do patients benefit from surgery?","volume":"61","author":"Rosbe","year":"2001","journal-title":"International Journal of Pediatric Otorhinolaryngology"},{"issue":"19","key":"10.1002\/14651858.CD012979.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic Fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012979.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MOO.0b013e3282fdc3c5","article-title":"Diseases associated with chronic rhinosinusitis: what is the significance?","volume":"16","author":"Ryan","year":"2008","journal-title":"Current Opinion in Otolaryngology & Head and Neck Surgery"},{"issue":"9","key":"10.1002\/14651858.CD012979.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/17476348.2018.1507741","article-title":"Tezacaftor for the treatment of cystic fibrosis","volume":"12","author":"Sala","year":"2018","journal-title":"Expert Reviews in Respiratory Medicine"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0074|cit74","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH on behalf of the CA and RMG and theCSMG Chapter 11: Presenting results and \u2018Summary of findings\u2019 tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0075|cit75","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD012979.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/alr.22082","article-title":"Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review","volume":"8","author":"Shah","year":"2018","journal-title":"International Forum of Allergy & Rhinology"},{"issue":"23","key":"10.1002\/14651858.CD012979.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s40136-017-0139-3","article-title":"Medical and surgical advancements in the management of cystic fibrosis chronic rhinosinusitis","volume":"5","author":"Tipirneni","year":"2017","journal-title":"Current Otorhinolaryngology Reports"},{"issue":"Pt 1","key":"10.1002\/14651858.CD012979.pub3-BIB0079|cit79","first-page":"269","article-title":"Distribution of mucus producing elements in the respiratory tract. Differences between upper and lower airway","volume":"128","author":"Tos","year":"1983","journal-title":"European Journal of Respiratory Diseases. Supplement"},{"issue":"5","key":"10.1002\/14651858.CD012979.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/lio2.78","article-title":"Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis","volume":"2","author":"Virgin","year":"2017","journal-title":"Laryngoscope Investigative Otolaryngology"},{"key":"10.1002\/14651858.CD012979.pub3-BIB0081|cit81","unstructured":"WHO Human Genetics Programme The molecular genetic epidemiology of cystic fibrosis: report of a joint meeting of WHO\/IECFTN\/ICF(M)A\/ECFS, Genoa, Italy 19 June 2002 apps.who.int\/iris\/handle\/10665\/68702"},{"issue":"1","key":"10.1002\/14651858.CD012979.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1172\/JCI112787","article-title":"Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro","volume":"79","author":"Wilson","year":"1987","journal-title":"Journal of Clinical Investigation"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T09:44:30Z","timestamp":1721295870000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012979.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":82,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012979.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]}}}